Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

3.6K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
3.6K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

3.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
3.4K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

70.1K
Overview
70.1K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

1.0K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
1.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Blood Rheology After Allogeneic Hematopoietic Stem Cell Transplantation or Gene Therapy in Sickle Cell Disease.

Blood advances·2026
Same author

Promoter reinforcement supports transcriptional resilience in drug-resistant cancer.

Nature structural & molecular biology·2026
Same author

Harmonizing standards and resources for the medical genome.

Nature·2026
Same author

The Underestimated Role of Environmental Factors in the Prevention of Invasive Fungal Disease: Experience From a European Childhood Cancer Centre.

Mycoses·2026
Same author

Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity.

bioRxiv : the preprint server for biology·2026
Same author

In Vivo CAR-Based Immune Cell Engineering: Future Applications and Challenges in Malignant Glioma.

Cancers·2026

相关实验视频

Updated: Aug 31, 2025

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.0K

在T细胞中的RASA2剥离增强了抗原敏感性和长期功能

Julia Carnevale1,2,3,4, Eric Shifrut5,6,7,8, Nupura Kale9,10

  • 1Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. julia.carnevale@ucsf.edu.

Nature
|August 24, 2022
PubMed
概括

研究人员确定RASA2是改进采用T细胞疗法的关键目标. 通过向RASA2增强T细胞功能,提高抗癌活性和持续性,为癌症治疗提供了新的希望.

更多相关视频

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

410
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.8K

相关实验视频

Last Updated: Aug 31, 2025

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.0K
A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

410
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.8K

科学领域:

  • 免疫学
  • 癌症生物学
  • 基因编辑

背景情况:

  • 采用T细胞治疗的疗效受到免疫抑制信号和内在抑制检查点的限制.
  • 有针对性的基因编辑为克服这些局限性和增强T细胞功能提供了一种策略.

研究的目的:

  • 在免疫抑制条件下使用全基因组CRISPR选来确定可以向T细胞功能障碍的基因.
  • 研究RASA2作为人类T细胞中的信号检查点的作用及其作为治疗点的潜力.

主要方法:

  • 在各种免疫抑制条件下进行多次全基因组CRISPR淘汰查.
  • 研究了RASA2在T细胞信号传递和功能中的作用,包括MAPK信号传递和CAR T细胞活性.
  • 在T细胞受体和CAR T细胞治疗的临床前模型中评估了RASA2剥离的疗效.

主要成果:

  • 镜聚焦在RASA2,一个RAS GTPase激活蛋白 (RasGAP),被确定为T细胞信号检查点.
  • RASA2 除增强了 MAPK 信号传递和仿真抗原受体 (CAR) T 细胞的细胞分解活性.
  • 缺乏RASA2的T细胞表现出增加的激活,细胞因子的产生,新陈代谢活动和持续性癌细胞杀死.
  • 在临床前模型中,RASA2- 淘汰的CAR- T细胞在体内表现出竞争力优势,RASA2 除延长了生存时间.

结论:

  • 在癌症治疗中,RASA2是增强T细胞持久性和效应器功能的有希望的标.
  • 向RASA2可以克服T细胞功能障碍并改善采用T细胞治疗的结果.
  • 针对RASA2的基因编辑策略有可能开发出更有效的癌症治疗方法.